Phreesia (PHR) Stock Price
Phreesia Price
Revenue has compounded at 26.4% per year over the past 8 years to 473.64 M USD. Phreesia's net margin stands at 0.5%, up from -56.0% several years earlier. Analysts set a median price target of 12.00 USD, implying 7.0% below the current price. Of 22 analysts, 13 rate the stock a buy — an overall Buy consensus.
Phreesia stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Phreesia business model & stock analysis
Frequently asked questions about Phreesia
The business model of Phreesia Inc is centered around providing patient intake and engagement solutions to healthcare organizations. By offering a comprehensive platform, Phreesia streamlines the registration process, collects patient information, verifies insurance eligibility, and facilitates payments. Their services aim to enhance operational efficiency, improve patient experience, and drive revenue growth for clients. Through innovative technology and data analytics, Phreesia empowers healthcare providers to effectively streamline their workflows, optimize patient care, and increase financial performance. The company focuses on delivering value to healthcare organizations by improving the patient journey and enabling a better patient-provider relationship.
Phreesia Inc is primarily active in the healthcare industry.
Some of the main competitors of Phreesia Inc in the market include athenahealth, Cerner Corporation, and athenathealth.
Phreesia Inc is a leading healthcare technology company that specializes in patient intake solutions. Founded in 2005, Phreesia has revolutionized the way healthcare organizations collect patient information, automate workflows, and enhance the patient experience. With their innovative platform, Phreesia has helped thousands of healthcare providers streamline their operations and improve patient engagement. By offering a patient-centric approach, Phreesia has become a trusted partner in the industry, empowering healthcare organizations to deliver high-quality care while reducing administrative burdens. With a strong track record of success and a commitment to innovation, Phreesia continues to be at the forefront of transforming healthcare delivery.
Phreesia Inc has achieved several significant milestones over the years. One of the notable achievements is their successful initial public offering (IPO) in July 2019, which allowed the company to raise substantial capital to fuel their growth. Furthermore, Phreesia has consistently expanded its client base, forging partnerships with numerous leading healthcare organizations across the United States. The company's innovative platform, which streamlines patient intake and payment processes, has garnered recognition and accolades, including being named one of the "50 Most Innovative Companies" by Fast Company in 2020. Phreesia's commitment to driving healthcare efficiency and enhancing patient experiences has positioned them as a prominent player in the industry.
Phreesia Inc is primarily present in the United States.
Phreesia Inc is a healthcare technology company that aims to improve patient experiences and streamline administrative tasks. With a focus on innovation and efficiency, Phreesia provides a comprehensive platform for healthcare providers to manage patient intake, payments, and engagement. The company's corporate philosophy revolves around empowering patients, enhancing clinical decision-making, and improving healthcare outcomes. By leveraging cutting-edge technology and patient-centric solutions, Phreesia strives to revolutionize the healthcare industry. Through its robust platform and commitment to delivering a seamless experience, Phreesia Inc showcases a dedication to advancing patient care and transforming the healthcare landscape.
Analysts currently set an average price target of 12.17 USD for the Phreesia stock (median: 12.00 USD), implying -3.6 % versus the latest price. The consensus is based on 22 analyst ratings.
22 analysts currently rate the Phreesia stock: 13 recommend buying, 9 holding and 0 selling.
Converted at the current exchange rate, the Phreesia share trades at 11.61 EUR (12.90 USD).
The Phreesia share (PHR) is listed on 5 stock exchanges, including: NYSE (PHR), London (0A23.L), Frankfurt (19P.F), München (19P.MU).
Phreesia Inc is a provider of technology-enabled services that optimize and improve patient traffic in medical practices and healthcare clinics. The company was founded in 2005 and is headquartered in New York City. Phreesia offers a wide range of services, such as patient registration, data entry, insurance verification, bill payment, appointment scheduling, and patient feedback. One of the company's most innovative products is the PhreesiaPad, an electronic tablet that automates paperwork during patient registration in the doctor's office. Phreesia has focused on the outpatient healthcare market, particularly medical practices and health centers, and has garnered numerous large clients, such as NewYork-Presbyterian Hospital and Duke University Medical Center. The company has developed comprehensive software that serves as the interface between physicians, insurance companies, and patients. Phreesia's core business is a subscription model, where customers pay a monthly fee to access the various services offered by the company. The company also partners with insurance companies to directly offer their services to patients. This leads to greater cost transparency and facilitates collaboration between physicians and insurance companies. Phreesia recently invested in telemedicine by partnering with SimplyWell, a digital health coaching company. This partnership allows Phreesia to offer a comprehensive platform for telemedicine and digital health solutions. Overall, Phreesia has developed a business model that enables easier collaboration and improves communication and transparency between physicians, patients, and insurance companies. By providing a comprehensive software solution that takes into account both the workflow in the practice and the requirements and expectations of patients, Phreesia has secured a solid position in the healthcare market.
The revenue of Phreesia is 473.64 M USD. This figure is based on current financial data and reflects the company's business performance.
The profit of Phreesia is 2.31 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Phreesia is currently 349.43. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Phreesia stock.
The price-to-sales ratio (P/S) of Phreesia is currently 1.70. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Phreesia stock.
The Eulerpool Quality Score for Phreesia is 3/10.
The ISIN of Phreesia is US71944F1066. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Phreesia is A2PMY3. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Phreesia is PHR. The ticker symbol is used to trade Phreesia shares on the stock exchange.
Phreesia stock
Phreesia Peer Group
Phreesia Ticker
Phreesia FIGI
All fundamentals and in-depth analysis of Phreesia
Our stock analysis for Phreesia stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Phreesia. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.